热门资讯> 正文

Lyra Therapeutics注册股票以通过认购权进行转售

2025-07-23 05:46

Lyra Therapeutics (NASDAQ:LYRA) registers 846,744 shares of common stock for resale by selling securityholders.
Shares are issuable upon exercise of outstanding warrants; company will receive proceeds only if exercised for cash.
Lyra will not receive proceeds from the resale of shares by securityholders.
Source: SEC filing

More on Lyra Therapeutics

Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst
Lyra Therapeutics to raise up to $15M via registered direct offering and concurrent private placement, stock falls 22%
Microcap Lyra Therapeutics surges 376% on phase 3 rhinosinusitis data
Seeking Alpha’s Quant Rating on Lyra Therapeutics
Historical earnings data for Lyra Therapeutics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。